To provide non-transplantable, human biomaterials for medical research, education and development, and other uses demonstrating scientific merit.
All requests for biomaterials will be considered. Availability will be contingent on donor referrals and criteria.
All applicants must complete and submit the IIAM Application/Biomaterials Transfer Agreement (BMTA), and Exhibits A-C.
IV. Biomaterials Use
Biomaterials shall be used only for the purposes cited in the Application, and may not be transferred to a 3rd party without prior written authorization from IIAM; such third party end-user shall have clearly demonstrated scientific, medical, or educational use for the biomaterials through written or electronic documentation. Notwithstanding the foregoing, IIAM consents to Applicant's use of biomaterials as described in and pursuant to Exhibit A. This information shall be used in part to ensure adequate tracking of biomaterials, and can be made available for inspection by any regulatory agency.
V. Research Precautions
IIAM will provide documentation of serological test results, and other donor demographic information. Researcher is responsible for using appropriate precautions in handling human biomaterials.
VI. Record Keeping
Applicant agrees to maintain and provide upon request by IIAM a timely and complete accounting of biomaterials received. This information shall be used in part to ensure adequate tracking of biomaterials, and can be made available for inspection by any regulatory agency. Upon approval of IIAM’s Application Review Committee, an executed copy of the BMTA will be returned to the applicant/researcher, and biomaterial placement will commence.
All researchers must acknowledge IIAM in any presentations or publications. A copy of any published material should be forwarded to IIAM.
For more information, contact IIAM.